Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 09 Jan 2007 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Quant Large & Mid Cap Fund |
|---|---|
| 09 Jan 2007 | ₹100.00 |
| 28 Aug 2008 | ₹81.30 |
| 17 Apr 2010 | ₹106.31 |
| 05 Dec 2011 | ₹90.11 |
| 24 Jul 2013 | ₹91.64 |
| 13 Mar 2015 | ₹180.69 |
| 30 Oct 2016 | ₹219.94 |
| 18 Jun 2018 | ₹222.04 |
| 05 Feb 2020 | ₹225.40 |
| 24 Sep 2021 | ₹380.35 |
| 14 May 2023 | ₹427.81 |
| 31 Dec 2024 | ₹691.80 |
| 20 Aug 2026 | ₹744.23 |
| Metric | quant · Regular · IDCW NAV ₹76.66 Very High risk ★★★★☆ | Category median Large & Mid Cap Fund · 35 funds |
|---|---|---|
| +10.91% | +3.02% | |
| +15.84% | +9.47% | |
| +16.58% | +9.57% | |
| +13.44% | +8.51% | |
| +10.78% | +8.27% | |
| +13.88% | — | |
| +13.24% | +10.05% | |
| +12.78% | +9.17% | |
| +12.58% | +6.32% | |
| Risk | ||
| 16.53% | 15.59% | |
| 0.56 | 0.10 | |
| 0.77 | 0.12 | |
| -54.71% | -42.76% | |
| Nifty Midcap 150 | — | |
| -0.96% | -5.64% | |
| 1.01 | 0.85 | |
| 91.8% | 79.3% | |
| 91.1% | 97.2% | |
| 2.45% | 2.30% | |
| ₹3,496Cr | ₹4,527Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| 0% | 40% | |
| Sanjeev Sharma | — | |
| 09 Jan 2007 | — | |
| 20 | — | |
| 64.0% | — | |
| 3.7% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.